- Long term outcome of hepatocellular carcinoma managed with an elective living donor liver transplantation strategy in high volume center
-
Sreekumar S, Gupta S, Agarwal S, Dey R
- KMID: 2535216
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S388.
- doi: 10.4285/ATW2022.F-5268
Patients with hepatocellular carcinoma (HCC) in chronic liver disease (CLD) awaiting deceased donor liver transplantation may progress or decompensate. Living donor liver transplantation (LDLT) offers an elective strategy for them... -
- CITED
-
- Close
- SHARE
-
- Close
